Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic Significance of PPFIA2 in Localized Prostate Cancer: Integrative Analysis and Functional Validation. | Anticancer Res | 2026 | 41617436 | PubTator, text mining | PubMed |
| High RMI1 expression is associated with cancer cell progression and poor prognosis in prostate cancer. | Oncol Rep | 2026 | 41614397 | PubTator, text mining | PubMed |
| Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. | Discov Oncol | 2026 | 41604018 | PubTator, text mining | PubMed |
| Paroxetine repurposing enhances antitumor immunity via SPOP-mediated PD-L1 ubiquitination and proteasomal degradation. | J Exp Clin Cancer Res | 2026 | 41593769 | PubTator, text mining | PubMed |
| Cannonball metastases as an initial presentation of urothelial bladder carcinoma: a case report and literature review. | Urol Case Rep | 2026 | 41552398 | PubTator, text mining | PubMed |
| CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy. | J Immunother Cancer | 2026 | 41534899 | PubTator, text mining | PubMed |
| Systematic Characterization of Cancer-Associated SPOP Mutants Reveals Novel and Reprogrammable Degradative Activities. | Chembiochem | 2026 | 41532714 | PubTator, text mining | PubMed |
| Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents. | Diabetes Metab J | 2026 | 41531286 | PubTator, text mining | PubMed |
| Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage. | Cancer Cell | 2026 | 41512867 | PubTator, text mining | PubMed |
| CodonMutator: a python-based automated oligonucleotide design framework for deep mutational scanning library construction. | BMB Rep | 2026 | 41407322 | PubTator, text mining | PubMed |
| TRIM24-mediated K27-linked ubiquitination of ULK1 alleviates energy stress-induced autophagy and promote prostate cancer growth in the context of SPOP mutation. | Cell Death Differ | 2026 | 40975747 | PubTator, text mining | PubMed |
| Precision Medicine in Prostate Cancer with a Focus on Emerging Therapeutic Strategies. | Biomedicines | 2025 | 41595588 | PubTator, text mining | PubMed |
| AI-Driven Digital Pathology: Deep Learning and Multimodal Integration for Precision Oncology. | Int J Mol Sci | 2025 | 41516254 | PubTator, text mining | PubMed |
| TAM Plasticity under androgen deprivation therapy and PARP inhibition in prostate cancer: a multi-omics perspective. | Front Immunol | 2025 | 41488638 | PubTator, text mining | PubMed |
| Exploiting Oxidative Stress as Achilles' Heel: From Redox Homeostasis to Ferroptosis in Prostate Cancer. | Antioxidants (Basel) | 2025 | 41462716 | PubTator, text mining | PubMed |
| Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis. | Ther Adv Med Oncol | 2025 | 41437938 | PubTator, text mining | PubMed |
| SPOP and HAUSP bidirectionally regulate LZTS2 ubiquitination to modulate the Wnt pathway. | Cell Death Dis | 2025 | 41436424 | PubTator, text mining | PubMed |
| Modulation of the tumor microenvironment by the ubiquitin-proteasome system in colorectal cancer. | J Transl Med | 2025 | 41361779 | PubTator, text mining | PubMed |
| Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer. | JCO Precis Oncol | 2025 | 41348987 | PubTator, text mining | PubMed |
| Systematic characterization of cancer-associated SPOP mutants reveals novel and reprogrammable degradative activities. | bioRxiv | 2025 | 41332736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=4